Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HCW Biologics (HCWB) EPS (Basic) (2021 - 2025)

Historic EPS (Basic) for HCW Biologics (HCWB) over the last 5 years, with Q3 2025 value amounting to -$2.02.

  • HCW Biologics' EPS (Basic) rose 5108.96% to -$2.02 in Q3 2025 from the same period last year, while for Sep 2025 it was $18.7, marking a year-over-year increase of 18994.71%. This contributed to the annual value of -$0.78 for FY2024, which is 1088.45% down from last year.
  • According to the latest figures from Q3 2025, HCW Biologics' EPS (Basic) is -$2.02, which was up 5108.96% from -$6.79 recorded in Q2 2025.
  • HCW Biologics' EPS (Basic)'s 5-year high stood at $0.05 during Q4 2021, with a 5-year trough of -$16.16 in Q2 2024.
  • Over the past 5 years, HCW Biologics' median EPS (Basic) value was -$0.14 (recorded in 2021), while the average stood at -$1.68.
  • As far as peak fluctuations go, HCW Biologics' EPS (Basic) skyrocketed by 9130.43% in 2022, and later plummeted by 1336666.67% in 2024.
  • Quarter analysis of 5 years shows HCW Biologics' EPS (Basic) stood at $0.05 in 2021, then plummeted by 420.0% to -$0.16 in 2022, then plummeted by 87.5% to -$0.3 in 2023, then soared by 70.72% to -$0.09 in 2024, then plummeted by 2199.44% to -$2.02 in 2025.
  • Its last three reported values are -$2.02 in Q3 2025, -$6.79 for Q2 2025, and -$0.05 during Q1 2025.